BioArctic AB (publ), a Swedish research-based biopharma company, announced that the first patient has been dosed with exidavnemab in the EXIST phase 2a study, in Parkinson’s disease patients ... key ...
The new Marie Skłodowska-Curie Doctoral Network AIPD is dedicated to investigating artificial intelligence methods to combat Parkinson's disease. It ...
A team of international researchers led by Professor Johan Jakobsson at Lund University has secured a 52 million SEK grant from the Aligning Science ...
In a Switzerland study, two people with spinal cord injuries received deep brain stimulation therapy and were able to walk without assistance and even climb stairs.
BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the first patient has been dosed with exidavnemab in the EXIST Phase 2a study, in Parkinson's disease patients. Exidavnemab is a ...
Home-baked cupcakes made by Sue Thomas, a member of the local branch to mark the branch’s 39th anniversary (Image: Parkinson's UK) The group meets regularly on the fourth Tuesday of each month at St ...